🏢 What does Cellebrite DI do?

Cellebrite DI (CLBT) is an Israeli company that provides digital intelligence software. It offers mobile forensic and investigative software that supports law enforcement agencies and enterprises in digital evidence collection and analysis, exposing it to digital investigation demand from government and public-sector customers.

The core business is providing mobile forensic and investigative software that supports digital evidence collection and analysis for law enforcement agencies and enterprises on a subscription basis. As a software company with strengths in its market position in digital forensics, its government customer base, and its AI analytics capabilities, its results are tied to subscription revenue growth and government demand.

Recent revenue is centered on digital intelligence subscriptions, with subscription revenue growth, government customers, and net customer expansion driving results. A market position in digital forensics and a government customer base provide stable demand, while AI analytics capabilities lift revenue per customer. As digital evidence grows, investigation demand rises structurally, and the results flow is shaped by subscription conversion, government demand, and net customer expansion.

📐 Cellebrite DI market cap and company size

The market cap is $3.1B, with 1,285 people employees.

As a digital intelligence company, it occupies a position comparable to security and analytics software peers such as RPD (Rapid7), TENB (Tenable), and QLYS (Qualys). Its strengths lie in its market position in digital forensics, its government customer base, and its AI analytics capabilities, in a structure where results are tied to subscription revenue growth and government demand.

📈 Cellebrite DI outlook and stock price trends

Key mid- to long-term growth drivers include the increase in digital evidence, law enforcement demand for digital investigations, the expansion of AI analytics, and subscription conversion along with the expansion of government customers. A market position in digital forensics and a government customer base provide stable demand, while AI analytics lifts revenue per customer. In the short term, however, government budgets and procurement schedules, geopolitical and regulatory factors, intensifying competition, and FX can act as sources of potential volatility.

• Growth in digital investigation demand
• Expansion of AI analytics
• Subscription conversion and expansion of government customers

⚔️ Cellebrite DI core competitive strengths and risks

Its strengths are its market position in digital forensics, its government customer base, and its AI analytics capabilities, while government budgets and procurement schedules, geopolitical and regulatory factors, intensifying competition, and FX are the key risks.

🔄 Cellebrite DI competitors and related (beneficiary) stocks

Comparable names in the security and analytics software space include RPD (Rapid7), TENB (Tenable), and QLYS (Qualys). Related names grouped under the security and analytics theme include PLTR (Palantir) in data analytics and CRWD (CrowdStrike) in security, sharing exposure to government and enterprise security demand.

✅ Cellebrite DI investor checkpoints

Key checkpoints when evaluating Cellebrite DI. Subscription revenue growth, expansion of government customers, AI analytics, government budgets, and geopolitical/regulatory factors act as key short- and medium-term variables.

A key risk is that government budgets and procurement schedules affect revenue. Geopolitical and regulatory changes, intensifying competition in digital intelligence, and FX volatility in its global business can also act as drivers of earnings and stock price volatility.

Cellebrite DI is a digital intelligence company with a market position in digital forensics, a government customer base, and AI analytics capabilities, with strengths in subscription conversion and benefiting from digital investigation demand. However, given its sensitivity to government budgets and geopolitical/regulatory factors, a dollar-cost averaging approach with a long-term perspective is recommended.